Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> Novartis Says Drug Reduces Symptoms in Childhood Arthritis
FDAnews Drug Daily Bulletin
June 8, 2012
| Vol. 9 No. 113
Novartis Says Drug Reduces Symptoms in Childhood Arthritis
Patients suffering from the most severe form of childhood arthritis were less likely to experience a flare up in the disease when using Novartis’ drug Ilaris compared to a placebo.
Reuters
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Mylan Launches Generic Tricor Tablets
Is the FDA Approving too Many Drugs Starting with X and Z?
Court Rejects Merck Deal Over Vioxx
Citizens in Poor EU States Can’t Afford Medicines, Health Promoters Say